• shareIcon

Potential malaria vaccine developed with 55% protection

Latest By Amrita Kumari , Onlymyhealth editorial team / May 11, 2016
Potential malaria vaccine developed with 55% protection


A new clinical study has shown promising data for vaccine development of malaria. There is no specific medication to cure malaria till date.


A new clinical study has shown promising data for vaccine development of malaria. There is no specific medication to cure malaria till date.

 

malaria

 

This new vaccine PfSPZ Vaccine has given 55% protection against disease. It has been tested with different doses in humans. This vaccine contains weakened P. falciparum sporozoites - the early developmental form of the parasite.

 

This vaccine is developed by Sanaria, a US-based pharmaceutical company. However, this vaccine showed result in small group of participants.

 

This study was conducted University of Maryland School of Medicine, Baltimore. In phase 1 clinical trial 101 healthy volunteers were enrolled aged between 18 to 45 years with no prior exposure to malaria.59 volunteers were  vaccinated and 32 served as control. Vaccine recipients were divided into several groups on the basis of roles of the route of administration, dose, and number of immunizations in conferring short- and long-term protection against malaria. This vaccine is easily dispersible with very less side effects.

 

In previous studies, this PfSPZ Vaccine was found to be most protective in initial three weeks of immunization. Further research is required to test the efficacy of this new promising vaccine.

 

Image Source : Getty

 

Read More : Health News

Disclaimer

All possible measures have been taken to ensure accuracy, reliability, timeliness and authenticity of the information; however Onlymyhealth.com does not take any liability for the same. Using any information provided by the website is solely at the viewers’ discretion. In case of any medical exigencies/ persistent health issues, we advise you to seek a qualified medical practitioner before putting to use any advice/tips given by our team or any third party in form of answers/comments on the above mentioned website.

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK